






Dental CRM and patient follow up should turn website, telephone, advertising and referral enquiries into a controlled patient journey. The commercial requirement is to know where the enquiry came from, respond consistently, book the right consultation, provide useful information and understand whether the opportunity became treatment.
WLW FUTURE’s UK dental consumer research found that quality, value and dentist knowledge and experience are important when patients consider a new practice. Those questions do not disappear after a form is submitted. Follow up needs to continue the same confidence building journey.
GDC standards require clear communication before, during and after treatment. ICO guidance also distinguishes genuine service messages, such as appointment reminders, from promotional direct marketing and sets rules for electronic marketing under PECR.
An enquiry has commercial value when the practice can identify the source, understand the treatment interest and move the person towards an appropriate next action.
Enquiries can be lost when responsibility changes between a website form, reception, treatment co ordinator, clinician and marketing team without a clear status or owner.
Patients considering higher value treatment may need information about the clinician, treatment, options, timing, cost or consultation before they are ready to decide.
Lead counts alone cannot show whether marketing created consultations, accepted treatment or revenue. The CRM and reporting model should connect acquisition activity to commercial outcomes.
WLW FUTURE’s dental consumer research was based on 382 completed responses. The study found that quality, value and dentist knowledge and experience all influence how people consider a new practice. CRM and follow up should continue the same decision making journey after the first enquiry.
Select the closest operational problem. The strongest fix depends on whether enquiries are being lost at capture, response, booking, follow up, reactivation or measurement.
Standardise the minimum information required for the next action. Capture source, treatment interest, contact details, preferred contact route and the information genuinely needed to route the enquiry. Avoid collecting unnecessary sensitive data.
Define ownership, status and handover rules. New enquiries should not sit between marketing, reception and treatment teams without a named owner and a visible next action.
Review the route from first response to consultation. Look for avoidable delays, unclear next steps, unavailable slots, weak treatment information and handovers which force the patient to repeat information.
Use structured follow up based on the patient’s question and stage. Give useful information, record what was sent and keep the next action visible. GDC standards recognise the need for clear information and enough time to consider treatment options.
Segment the database before contacting people. Separate service communication from direct marketing, verify the lawful basis and applicable PECR position and respect objections, opt outs and suppression lists.
Connect source, consultation outcome, treatment outcome and accepted value. This creates a commercial view of which acquisition sources produce useful patient demand instead of measuring lead volume alone.
| Information | Why it matters | Operational use |
|---|---|---|
| Source | Shows where the enquiry originated | Marketing attribution and campaign improvement |
| Treatment interest | Provides context for the conversation | Routing, follow up and reporting |
| Preferred contact route | Supports a practical response | Call, email or other permitted communication |
| Enquiry status | Shows what should happen next | Ownership and pipeline control |
| Consultation outcome | Separates lead volume from genuine opportunity | Commercial reporting |
| Treatment outcome | Shows whether acquisition produced value | Revenue attribution and optimisation |
Every new enquiry needs a visible owner and status so responsibility does not disappear between teams or systems.
The response should reflect the treatment or question the person raised instead of starting with a generic sales script.
Make the appropriate route clear, whether it is a call, consultation, information request or another agreed step.
Reception, treatment co ordinators and clinicians should be able to see the relevant previous contact and current status.
Use clear treatment, clinician and practical information to support informed decisions without creating pressure.
Record whether contact was made, a consultation was booked and the enquiry progressed, paused or closed.
Follow up should be useful to the patient and measurable for the practice. The objective is to answer the next genuine question, keep the agreed action clear and give people enough information and time to consider treatment.
Use the treatment interest and previous contact to make follow up relevant. Avoid forcing the patient to repeat information already supplied.
Useful follow up may cover treatment options, clinician experience, practical steps, timing, consultation arrangements or other questions raised by the patient.
Record whether the patient wants a consultation, more information, contact at a later point or no further marketing communication.
GDC standards recognise that patients need enough information and time to consider treatment options.
Reactivation can include lapsed enquiries, patients due for appropriate contact or former treatment prospects. The database should be cleaned and segmented before any promotional programme is considered.
Appointment reminders and purely administrative service messages are treated differently from promotional direct marketing. Promotional email and text activity must follow PECR and data protection requirements.
ICO guidance says genuine administrative messages such as appointment reminders can fall outside direct marketing when they contain no promotional material. Adding promotional content can turn the communication into direct marketing.
GDC standards require complete and accurate patient records and appropriate protection of patient information. Marketing systems should use only the information needed for the purpose, respect confidentiality and avoid creating unnecessary copies of sensitive patient data.
Decide which system owns the authoritative patient record and which information belongs in a marketing or enquiry management system.
Do not copy clinical or other sensitive information into marketing tools simply because an integration makes it possible.
Consent, objections and opt outs need to be visible to the systems and people responsible for future communication.
Service messages, consent, marketing preferences, patient information and record keeping need clear operational rules.
The useful commercial question is which acquisition activity produces appropriate consultations and accepted treatment. Reporting should connect marketing source with patient journey outcomes without turning clinical data into unnecessary marketing data.
| Measure | Question it answers | Why it is commercially useful |
|---|---|---|
| Enquiries by source | Which channels create contact? | Shows demand volume |
| Contact rate | How many enquiries receive a successful response? | Exposes response and data quality problems |
| Consultation booking rate | How many relevant enquiries reach consultation? | Shows whether the enquiry journey is progressing |
| Consultation outcome | What happens after consultation? | Separates activity from genuine opportunity |
| Treatment value by source | Which acquisition sources produce commercial value? | Supports better marketing investment decisions |
WLW’s dental work has included digital strategy, research, brand, advertising, websites, SEO, PPC and media. Our wider healthcare work also includes CRM, lead management and patient journey design.
The practical advantage is the ability to review the complete route from the message and landing page through enquiry capture, response, consultation, follow up and commercial measurement.
Lead capture
Response and booking
Patient information
CRM and follow up
Reactivation
Commercial measurement
WLW can review forms, calls, response times, booking, CRM capture, patient follow up, marketing permissions, reactivation and source to treatment reporting as one commercial journey.
Book a 15 minute requirements callA dental CRM can be used to organise enquiries, follow up, source tracking, consultation status and marketing activity around the patient acquisition journey. It should complement the practice’s clinical and patient record systems rather than create uncontrolled duplicates of sensitive information.
Use a defined owner, clear response standards and enough context about the treatment enquiry to answer the immediate question and arrange the appropriate next step. Follow up should be consistent and measurable.
ICO guidance treats purely administrative appointment reminders as service messages rather than direct marketing. If promotional material is added, the message can become direct marketing and the relevant PECR rules apply.
Promotional email to individuals is subject to PECR. Consent or an applicable soft opt in may be required and practices must respect objections and opt outs. The precise position depends on how the details were collected and the relationship with the individual.
Track source, treatment interest, contact outcome, response time, consultation booking, consultation outcome and accepted treatment value where appropriate. This allows marketing performance to be judged beyond raw lead volume.
The right architecture depends on the systems in use. Define a source of truth, minimise unnecessary sensitive data and make sure integrations support accurate records, confidentiality and marketing preferences.